10x Genomics (TXG) Cash & Equivalents Growth (1y) (2019 - 2026)
Powered by 
Analysis
10x Genomics (TXG) Cash & Equivalents Growth (1y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 226.93 Bn | 222.99 Bn | 8.34 Bn | -11.19% |
| 2 | Danaher | 145.94 Bn | 141.60 Bn | 3.61 Bn | 47.04% |
| 3 | Agilent Technologies | 42.55 Bn | 40.79 Bn | 1.04 Bn | 14.53% |
| 4 | Illumina | 32.95 Bn | 31.78 Bn | 770.00 Mn | 11.35% |
| 5 | Revvity | 14.53 Bn | 13.51 Bn | 416.87 Mn | 3.13% |
| 6 | Bio-Techne | 11.31 Bn | 11.04 Bn | 211.39 Mn | 63.22% |
| 7 | Bio-Rad Laboratories | 10.34 Bn | 8.72 Bn | 345.80 Mn | 39.99% |
| 8 | Repligen | 9.46 Bn | 8.44 Bn | 110.04 Mn | 14.33% |
| 9 | Bruker | 8.91 Bn | 8.73 Bn | 416.00 Mn | 100.98% |
| 10 | 10x Genomics | 8.16 Bn | 7.61 Bn | 112.50 Mn | 26.35% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.35% |
| Mar 31, 2026 | 30.03% |
| Dec 31, 2025 | 37.75% |
| Sep 30, 2025 | 8.63% |
| Jun 30, 2025 | 4.71% |
| Mar 31, 2025 | 5.98% |
| Dec 31, 2024 | -4.24% |
| Sep 30, 2024 | 27.92% |
| Jun 30, 2024 | 16.55% |
| Mar 31, 2024 | 7.06% |
| Dec 31, 2023 | 63.50% |
| Sep 30, 2023 | 33.05% |
| Jun 30, 2023 | 18.85% |
| Mar 31, 2023 | 6.35% |
| Dec 31, 2022 | -62.59% |
| Sep 30, 2022 | -61.04% |
| Jun 30, 2022 | -55.92% |
| Mar 31, 2022 | -49.37% |
| Dec 31, 2021 | -11.48% |
| Sep 30, 2021 | -21.90% |